eTOPIX_Immune Proteins with Enhanced Activity & Stability – Sent on 30 June 2022



If you can't see this e-mail properly, view it online
 
eTOPIX

Immune Proteins with
Enhanced Activity & Stability

 


 

AdipoGen Life Sciences specializes in the production of recombinant proteins in mammalian cells that show Enhanced Activity and Stability. Using proprietary in-house technologies together with established and published technologies, we engineer, develop and produce an innovative panel of recombinant proteins for different research fields including Cell Therapy Research.
 

 
Better Solutions for in vivo and in vitro Research
 

 
NEW Monomeric Proteins fused to Fc (KIH-Technology)
 
Monomeric KIH ProteinsAdipoGen Life Sciences developed various interleukins (e.g. IL-2, IL-37 and IL-38) into an Fc-fusion protein using the knobs-into-holes (KIH) technology. The final KIH proteins are monomeric with greatly enhanced stability and improved pharmacokinetics (PK) while maintaining the cytokine activity.






 

SELECTED PRODUCTS:






Discover More   

 
TNF Ligands Multimeric Proteins / MultimericLigands
 
Multimeric ProteinsEndogenous TNF superfamily ligands are either active as membrane-form (e.g. FasL, TRAIL, CD40L, OX40L) or are secreted and activated through oligomerization by the binding of proteoglycans at the surface of cells (e.g. APRIL).

MultimericLigands™ are constructs in which two trimeric TNFSF ligands are linked via the oligomeric collagen domain of Adiponectin [ACRP30headless], mimicking the natural membrane-assisted aggregation of natural ligands.

 
SELECTED PRODUCTS: 



Discover More   

 
COMP-Fusion Proteins
 
Comp FusionProteinsCOMP-Fusion Proteins are based on the pentamerization domain (minimal coiled-coil domain) of the cartilage oligomeric matrix protein (COMP), which is fused through a specific linker to proteins of interest. Using this technology AdipoGen Life Sciences generates cytokines with improved avidity and biological activity.

 
SELECTED PRODUCTS: 



Discover More   

 
Fc-Fusion Proteins (wild-type or non-lytic)
 
Fc Fusion ProteinsThe fusion of a cytokine sequence to the Fc domain of an IgG (human or mouse) determines a prolonged circulating half-life in vivo. The Fc domain folds independently and can improve the solubility and stability of the partner molecule both in vitro and in vivo. Non-lytic versions contain mutations to the complement (C1q) and FcgR I binding sites of the IgGs Fc fragment render the fusion proteins incapable of antibody-directed cytotoxicity (ADCC) and complement-directed cytotoxicity (CDC).

 
SELECTED PRODUCTS: 




Discover More   

 
Custom Manufacturing & Bulk Quantities of
Proteins with Enhanced Activity & Stability

 
Contact AdipoGen Life Sciences for custom manufacturing and bulk quantities of any protein using above indicated technologies.
 
  • KIH-Technology
  • Multimeric TNF Ligands
  • COMP-Fusion Proteins
  • Fc-Fusion Proteins

 

 


 

Privacy Policy

You are receiving this e-mail because you have interacted with us in some way over the past 10 years. You might have purchased products from us, had technical discussions with our staff or attended a conference sponsored by AdipoGen Life Sciences. You can always update your mailing preferences and opt out of any marketing communications by clicking on the links at the bottom of every email we send you – including this one!

If, for any reason, you would rather not be contacted anymore, please unsubscribe below now.

 

INFLAMMATION & IMMUNE RESPONSES
 
 
 
 
Visit our Website www.adipogen.com

For Ordering please visit: www.adipogen.com
Adipogen Life Sciences | info@adipogen.com | Privacy Policy
Products are for research use only. Not for human therapeutics or diagnostics use.

 
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.